Healthcare software company Castlight Health Inc (NYSE:CSLT) which debuted earlier this month, has doubled from its offering price. Biotech Dicerna Pharmaceuticals (DRNA), which went public in late January, is up nearly 180%. So is Auspex Pharmaceuticals (ASPX), which started trading in early February. Castlight Health Inc (NYSE:CSLT) shares after opening at $23.00 moved to $24.00 on last trade day and at the end of the day closed at $21.42. Company price to sales ratio in past twelve months was calculated as 142.64 and price to cash ratio as 27.59. Castlight Health Inc (NYSE:CSLT) showed a negative weekly performance of -27.02 %.
Shutterfly (NASDAQ:SFLY) CEO Jeffrey T. Housenbold sold 39,979 shares of the company’s stock on the open market in a transaction dated Monday, March 24th. The stock was sold at an average price of $44.53, for a total value of $1,780,264.87.Shutterfly, Inc. (NASDAQ:SFLY) shares fell -1.50% in last trading session and ended the day on $41.39. SFLY return on equity ratio is recorded as 1.30% and its return on assets is 0.90%. Shutterfly, Inc. (NASDAQ:SFLY) yearly performance is -6.29%.
General Cable Corporation (NYSE:BGC) announced first quarter adjusted operating income is expected to be below the Company’s previously communicated outlook. The Company now expects to generate adjusted operating income in the range of $17 to $27 million in the first quarter of 2014. The Company’s previous outlook was $30 to $45 million. General Cable Corporation (NYSE:BGC) shares moved down -1.01% in last trading session and was closed at $25.53 while trading in range of $25.50 -$25.86 – General Cable Corporation (NYSE:BGC) year to date (YTD) performance is -13.19%.
The Medicines Company (NASDAQ:MDCO) SVP William Bernard O’connor sold 2,968 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $30.31, for a total transaction of $89,960.08. The Medicines Company (NASDAQ:MDCO) weekly performance is -5.17%. On last trading day company shares ended up $27.90. The Medicines Company (NASDAQ:MDCO) distance from 50-day simple moving average (SMA50) is -13.57%. Analysts mean target price for the company is $37.82.